Effectively communicating risk

Communications / 24 February 2022

Photo: iStock

Informing patients and the public about risks is tricky. UMC's latest podcast digs into the evidence about what works best, and examines the proper role of health communicators.

People’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion.

Alexandra Freeman from the Winton Centre for Risk and Evidence Communication joins the Drug Safety Matters podcast to discuss how to give patients the information they need to decide what's best for them. This fascinating episode challenges assumptions about the role of the narratives in health communication and provides practical, evidence-backed guidance for conveying effective, ethical information about the potential harms and benefits of medicines and vaccines.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

You may also like

Peter Hjelmström joins UMC as new director

Uppsala Monitoring Centre (UMC), the WHO Collaborating Centre for International Drug Monitoring, is pleased to announce the arrival of its new director Peter Hjelmström.

Communications / 06 March 2023

UMC revamps medicines safety cycle

By putting the patient front and centre, UMC is helping countries in the WHO Programme for International Drug Monitoring to promote the safer use of medicines globally.

Communications / 10 November 2022

“Living better lives”

UMC pays homage to a trailblazer in pharmacovigilance, Dr. Ed Napke

Communications / 14 March 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more